-
April 20, 2022
Triplet Combination Improves Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer Bookmark
George Lundberg, MDMetastatic carcinoma of the prostate is fatal, but a 3-drug combination treatment can prolong life substantially, according to new clinical trial results outlined by The ASCO Post.
.
-
April 6, 2022
Essential Breast Cancer Treatment Trends in 2022: Webinar Highlights
Sarah StanleyWomen with breast cancer often face an overwhelming amount of information to sort through and decisions to make. Whether newly diagnosed or starting a next step in treatment, they may wonder: What does the latest research say about my type of breast cancer? Should I enroll in a clinical trial? How do I know if I’m receiving my best-possible treatment? Every day, Cancer Commons… Read more »
-
March 8, 2022
Hepatocellular Carcinoma in 2021: An Exhaustive Update Bookmark
George Lundberg, MDThis exhaustive scientific review was published by Cureus in 2021, but remains relevant now. It explores current molecular understanding of hepatocellular carcinoma—the most common type of cancer that starts in the liver—as well as a very large range of diagnostic and treatment options.
.
-
February 18, 2022
Palliative Care Options for a Young Adult Patient with a Diffuse Intrinsic Pontine Glioma Bookmark
George Lundberg, MDThis clinical case study published in the scientific journal Cureus suggests that intelligent, compassionate, palliative care is likely the best approach to this very difficult brain tumor.
.
-
February 18, 2022
Chemotherapy: Before Surgery Vs. After Surgery Bookmark
George Lundberg, MDAccording to this article from the Cochrane Database of Systematic Reviews, chemotherapy administered before surgery may be beneficial for people with advanced ovarian cancer.
.
-
February 18, 2022
This New Ovarian Cancer Treatment Could Improve Survival Rates Bookmark
George Lundberg, MDRecently approved by the U.S. Food and Drug Administration (FDA), the drug Cytalux is given to ovarian cancer patients to allow surgeons to recognize cancer cells more clearly, promoting more complete surgical removal of tumors. Learn more in this story from The Philadelphia Inquirer.
.
-
February 8, 2022
Facing Esophageal Cancer in 2022
Kaumudi Bhawe, PhDDifficulty swallowing, a hoarse voice, or heartburn has led to the dreaded diagnosis of esophageal cancer. What now? Origin, Types, and Stages of Esophageal Cancer If you or a loved one face esophageal cancer, it can be helpful to start by learning more about the disease and your particular diagnosis. Then, you will be prepared to learn about esophageal cancer treatments. Esophageal cancer originates… Read more »
-
February 3, 2022
Kidney Cancer Clinical Trials at UCSD Bookmark
George Lundberg, MDEnrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Diego, keeps a running list of clinical trials offered there that are currently enrolling people with kidney cancer.
.
-
February 3, 2022
Kidney Cancer Clinical Trials at UCSF Bookmark
George Lundberg, MDEnrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Francisco, keeps a running list of clinical trials offered there that are currently enrolling people with kidney cancer.
.
-
February 3, 2022
Bladder Cancer Clinical Trials at UCSD Bookmark
George Lundberg, MDEnrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Diego, keeps a running list of clinical trials offered there that are currently enrolling people with bladder cancer.
.